帕克利塔塞尔分布在化学疗法诱导的外周神经病变相关的解剖部位上的配方依赖差异
Milda Girdenytė1,2, Yang Hu1, Aghavni Ginosyan1
1Translational Pharmacokinetics/Pharmacodynamics Group (tPKPD), Department of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.
Frontiers in pharmacology
|November 21, 2024
概括
帕克利塔塞尔配方影响化疗诱导的外周神经病变 (CIPN) 风险. 没有cremophor的paclitaxel (nab-PTX,micellar-PTX) 与传统的CreEL-PTX相比,在神经部位的分布更高,可能会增加CIPN风险.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 神经科学是一个神经科学.
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 是帕克利塔塞尔显著的剂量限制毒性.
- 帕克利塔塞尔配方,包括CreEL-PTX,nab-PTX和小胞-PTX,表现出不同的CIPN流行率.
- 跨血组织屏障的帕克利塔塞尔分布的差异可能解释了CIPN患病率的变化.
研究的目的:
- 调查帕克利塔塞尔配方在周围神经系统部位的分布.
- 为了比较不同配方的帕克利塔克塞尔分布:CreEL-PTX,nab-PTX和micellar-PTX.
- 为了阐明帕克利塔塞尔分布和CIPN风险之间的关系.
主要方法:
- 在Sprague Dawley大鼠中使用了CIPN的组合映射方法.
- 在4小时输液后确定未结合的组织与血度比 (Kp,uu,tissue).
- 测量Kp,uu,tissue在背部根 (DRG),坐骨神经,大脑,脊髓和骨肌中.
主要成果:
- 与CreEL-PTX (0.27) 相比,没有克雷莫福的帕克利塔塞尔配方 (nab-PTX,小胞-PTX) 在CIPN位点 (例如,Kp,uu,DRG 0.70和0.60) 的分布明显更高.
- 血中未结合的帕克利塔塞尔的分量对于NAB-PTX (0.061) 和微粒-PTX (0.065) 与CreEL-PTX (0.039) 相比,是NAB-PTX的1.6倍.
- 这些发现表明,新配方的帕克利塔塞尔更容易透到神经组织中.
结论:
- 与CreEL-PTX相比,NAB-PTX和状PTX配方可以导致CIPN站点中的帕克利塔塞尔暴露率更高.
- 了解帕克利塔克塞尔的分布对于预测和潜在地减轻CIPN至关重要.
- 药物配方依赖的药物分发影响了化疗诱导的外围神经病变的风险.
相关概念视频
Local Anesthetics: Differential Sensitivity of Nerve Fibers
772
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
772
Tissue-Drug Binding: Localization of Drugs and its Significance
67
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
67
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
Local Anesthetics: Pharmacokinetics
733
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
733


